Citations

Showing 10 of 108094 citations.

Diagnosis of Attention Deficit Hyperactivity Disorder by Using MR Imaging and Radiomics: A Potential Tool for Clinicians
Port, John D. , Port, John D

Mayo Clinic

Radiology | April 18, 2018 | Volume: 287 | Issue: 2 | Pages: 631-632

10.1148/radiol.2018172804 | PMID 29668406 Get It

The outlet patch: gastric heterotopia of the colorectum and anus
Mannan, Abul Ala Syed Rifat , Vieth, Michael , Khararjian, Armen , Khandakar, Binny , Lam‐Himlin, Dora , Heydt, David, Bhaijee, Feriyl , Venbrux, Henry J, Voltaggio, Lysandra , Barker, Norman, Yuan, Songyang, Mannan, Abul A S R , Byrnes, Kathleen , Montgomery, Elizabeth Anne

Mayo Clinic

Histopathology | April 18, 2018 | Volume: 73 | Issue: 2 | Pages: 220-229

10.1111/his.13632 | PMID 29667709 Get It

AimsGastric heterotopia (GH) has been described throughout the gastrointestinal tract. However, the colorectal region is an extremely rare location for it. We describe the clinicopathological features of GH of the colon, rectum and anus.Methods and resultsWe identified 33 cases in 20 males and 13 females (median age = 54 years; range = 4 months–73 years). Sites included the rectum (n = 26), anus (n = 4), ileocaecal junction (n = 1), ascending colon (n = 1) and descending colon (n = 1). Presenting symptoms (n = 27) included haematochezia (41%) and altered bowel habits (4%); 15 patients (55%) were asymptomatic. On colonoscopy (n = 31), all appeared as solitary lesions (median size = 6.5 mm, range = 2–55 mm), either as polyps (61%), raised erythematous patches (23%), an ulcer (10%), within a rectal diverticulum (3%) or a haemorrhoid (3%). Patients were managed by polypectomy. One with an associated carcinoma in the area of GH underwent resection. No morbidity related to GH itself was reported following excision. Histologically, heterotopic gastric mucosa was oxyntic (85%), mixed oxyntic and non‐oxyntic (12%) and not specified (3%) types. In five patients a pyloric gland adenoma (PGA) arose from heterotopic gastric mucosa, two of which contained a focus of invasive adenocarcinoma. One case had associated surface foveolar‐type low‐grade dysplasia. Another had associated adenocarcinoma arising from the heterotopic mucosa. One example harboured Helicobacter pylori organisms.ConclusionsWe highlight the features of GH in the distal GIT – the ‘outlet patch’. Association with PGA, surface dysplasia and adenocarcinoma suggests that lower tract GH can undergo neoplastic transformation.
Antigen-mediated regulation in monoclonal gammopathies and myeloma
Nair, Shiny , Sng, Joel , Boddupalli, Chandra Sekhar , Seckinger, Anja , Chesi, Marta , Fulciniti, Mariateresa , Rauniyar, Navin , Parker, Terri L., Munshi, Nikhil C. , Sexton, Rachael, Barlogie, Bart , Orlowski, Robert Z. , Bergsagel, Leif, Hose, Dirk , Meffre, Eric , Dhodapkar, Madhav V. , Bergsagel, P. Leif , Bergsagel, P. Leif , Orlowski, Robert Z. , Zhang, Lin, Lopez, Michael A. , Neparidze, Natalia , Flavell, Richard A. , Mistry, Pramod K. , Hose, Dirk

Mayo Clinic

JCI Insight | April 18, 2018 | Volume: 3 | Issue: 8 | Pages: No page available

10.1172/jci.insight.98259 | PMID 29669929 Get It

A role for antigen-driven stimulation has been proposed in the pathogenesis of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM) based largely on the binding properties of monoclonal Ig. However, insights into antigen binding to clonal B cell receptors and in vivo responsiveness of the malignant clone to antigen-mediated stimulation are needed to understand the role of antigenic stimulation in tumor growth. Lysolipid-reactive clonal Ig were detected in Gaucher disease (GD) and some sporadic gammopathies. Here, we show that recombinant Ig (rIg) cloned from sort-purified single tumor cells from lipid-reactive sporadic and GD-associated gammopathy specifically bound lysolipids. Liposome sedimentation and binding assays confirmed specific interaction of lipid-reactive monoclonal Ig with lysolipids. The clonal nature of lysolipid-binding Ig was validated by protein sequencing. Gene expression profiling and cytogenetic analyses from 2 patient cohorts showed enrichment of nonhyperdiploid tumors in lipid-reactive patients. In vivo antigen-mediated stimulation led to an increase in clonal Ig and plasma cells (PCs) in GD gammopathy and also reactivated previously suppressed antigenically related nonclonal PCs. These data support a model wherein antigenic stimulation mediates an initial polyclonal phase, followed by evolution of monoclonal tumors enriched in nonhyperdiploid genomes, responsive to underlying antigen. Targeting underlying antigens may therefore prevent clinical MM.
CX3CR1 identifies PD-1 therapy–responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy
Yan, Yiyi , Cao, Siyu , Liu, Xin , Harrington, Susan M. , Bindeman, Wendy , Adjei, Alex A. , Jang, Jin Sung , Jen, Jin, Li, Ying , Chanana, Pritha , Mansfield, Aaron S. , Dronca, Roxana , Dong, Haidong , Mansfield, Aaron S , Dong, Haidong , Park, Sean S. , Markovic, Svetomir N.

Mayo Clinic

JCI Insight | April 18, 2018 | Volume: 3 | Issue: 8 | Pages: No page available

10.1172/jci.insight.97828 | PMID 29669928 Get It

Although immune checkpoint inhibitors have resulted in durable clinical benefits in a subset of patients with advanced cancer, some patients who did not respond to initial anti–PD-1 therapy have been found to benefit from the addition of salvage chemotherapy. However, the mechanism responsible for the successful chemoimmunotherapy is not completely understood. Here we show that a subset of circulating CD8 + T cells expressing the chemokine receptor CX3CR1 are able to withstand the toxicity of chemotherapy and are increased in patients with metastatic melanoma who responded to chemoimmunotherapy (paclitaxel and carboplatin plus PD-1 blockade). These CX3CR1 + CD8 + T cells have effector memory phenotypes and the ability to efflux chemotherapy drugs via the ABCB1 transporter. In line with clinical observation, our preclinical models identified an optimal sequencing of chemoimmunotherapy that resulted in an increase of CX3CR1 + CD8 + T cells. Taken together, we found a subset of PD-1 therapy–responsive CD8 + T cells that were capable of withstanding chemotherapy and executing tumor rejection with their unique abilities of drug efflux (ABCB1), cytolytic activity (granzyme B and perforin), and migration to and retention (CX3CR1 and CD11a) at tumor sites. Future strategies to monitor and increase the frequency of CX3CR1 + CD8 + T cells may help to design effective chemoimmunotherapy to overcome cancer resistance to immune checkpoint blockade therapy.
A Disposable Tear Glucose Biosensor—Part 5: Improvements in Reagents and Tear Sampling Component
Lin, Chi, Ito, Yuka , Deng, Anna, Johns, Jared, Matloff, Daniel S., Sode, Koji , Belle, Jeffrey T. La , Cook, Curtiss B. , La Belle, Jeffrey T, Sode, Koji

Mayo Clinic

Journal of Diabetes Science and Technology | April 18, 2018 | Volume: 12 | Issue: 4 | Pages: 842-846

10.1177/1932296818769944 | PMID 29667855 Get It

A tear glucose (TG) sensor with an integrated tear sampler can provide a noninvasive method for calibrating the continuous TG contact lens and monitoring glucose. Expanding from previous work, an improved TG sensor that implements dried reagents, genetically modified glucose dehydrogenase (GDH), and a tear sampler was developed and compared against the TG sensor prepared with commercial GDH. It was found that neither sensor was affected by the tear interferents: ascorbic acid, acetaminophen, and uric acid. The sensor prepared with commercial GDH generated higher current. This suggests that using enzymes with lower K m may be advantageous when operating in low glucose environments like tears. The improved TG sensor also demonstrated the potential of integrating Schirmer’s test strip as a tear sampler for self-monitoring of TG.
Rediscovering the Orbit of Percutaneous Coronary Intervention After ORBITA
Bhatt, Deepak L. , Steg, Philippe Gabríel , Harrington, Robert A. , Windecker, Stephan , Bhatt, Deepak L , Gersh, Bernard J. , Steg, P Gabriel , Windecker, Stephan

Mayo Clinic

Circulation | April 18, 2018 | Volume: 137 | Issue: 23 | Pages: 2427-2429

10.1161/circulationaha.118.034596 | PMID 29669787 Get It

Beliefs and practice patterns in hyperleukocytosis management in acute myeloid leukemia: a large U.S. web-based survey
Stahl, Maximilian , Pine, Alexander B. , Litzow, Mark R. , Luger, Selina M. , Stone, Richard M. , Kim, Tae Kon , Sekeres, Mikkael A. , Komrokji, Rami S. , Gore, Steven D. , Zeidan, Amer M. , Litzow, Mark R. , Komrokji, Rami S , Sekeres, Mikkael A , Kim, Tae Kon , Hendrickson, Jeanne E. , Erba, Harry Paul , Steensma, David P. , Zeidan, Amer M

Mayo Clinic

Leukemia & Lymphoma | April 18, 2018 | Volume: 59 | Issue: 11 | Pages: 2723-2726

10.1080/10428194.2018.1452219 | PMID 29667455 Get It

Conscientious objection by healthcare professionals to end-of-life organ donation practices: A response to Shaw et al
Verheijde, Joseph L., Rady, Mohamed Y, Rady, Mohamed Y

Mayo Clinic

Journal of the Intensive Care Society | April 18, 2018 | Volume: 19 | Issue: 4 | Pages: NP2-NP4

10.1177/1751143718769041 | PMID 30515247 Get It

Endosomal receptor trafficking: Retromer and beyond
Wang, Jing , Fedoseienko, Alina , Chen, Baoyu , Billadeau, Daniel D. , Billadeau, Daniel D , Burstein, Ezra , Jia, Da

Mayo Clinic

Traffic | April 18, 2018 | Volume: 19 | Issue: 8 | Pages: 578-590

10.1111/tra.12574 | PMID 29667289 Get It

The tubular endolysosomal network is a quality control system that ensures the proper delivery of internalized receptors to specific subcellular destinations in order to maintain cellular homeostasis. Although retromer was originally described in yeast as a regulator of endosome‐to‐Golgi receptor recycling, mammalian retromer has emerged as a central player in endosome‐to‐plasma membrane recycling of a variety of receptors. Over the past decade, information regarding the mechanism by which retromer facilitates receptor trafficking has emerged, as has the identification of numerous retromer‐associated molecules including the WASH complex, sorting nexins (SNXs) and TBC1d5. Moreover, the recent demonstration that several SNXs can directly interact with retromer cargo to facilitate endosome‐to‐Golgi retrieval has provided new insight into how these receptors are trafficked in cells. The mechanism by which SNX17 cargoes are recycled out of the endosomal system was demonstrated to involve a retromer‐like complex termed the retriever, which is recruited to WASH positive endosomes through an interaction with the COMMD/CCDC22/CCDC93 (CCC) complex. Lastly, the mechanisms by which bacterial and viral pathogens highjack this complex sorting machinery in order to escape the endolysosomal system or remain hidden within the cells are beginning to emerge. In this review, we will highlight recent studies that have begun to unravel the intricacies by which the retromer and associated molecules contribute to receptor trafficking and how deregulation at this sorting domain can contribute to disease or facilitate pathogen infection.
A brief bedside visual art intervention decreases anxiety and improves pain and mood in patients with haematologic malignancies
Saw, Jessica J. , Curry, Elizabeth A., Ehlers, Shawna L. , Scanlon, Paul D., Bauer, Brent A. , Rian, Johanna , Wolanskyj, Alexandra P. , Saw, J J , Wolanskyj-Spinner, Alexandra P , Larson, Dirk R.

Mayo Clinic

European Journal of Cancer Care | April 18, 2018 | Volume: 27 | Issue: 4 | Pages: e12852

10.1111/ecc.12852 | PMID 29667288 Get It